news

News

Cytena and Molecular Devices expand their partnership to launch the f.sight and c.sight in North America

Cytena is x.sighted to announce the launch of the f.sight and c.sight in North America.

Freiburg, Germany - Molecular Devices, LLC, a leader in protein and cell biology technologies, announced an expansion in its partnership with cytena GmbH to launch the x.sight series in North America. Building on cytena`s success of the single-cell printer system, the new family evolves both the ease of use for image-based isolation and documentation of single cells and adds fluorescent sorting for further enrichment of monoclonal cell lines.

 

EUR 3 million in series A for the growth and development of Cytena GmbH

  • Two private investors and High-Tech Gründerfonds (HTGF) are convinced of the importance of single-cell isolation for the production of biopharmaceuticals and for genetic analysis in research and diagnostics.
  • EUR 3 million will be invested in the further development of the technology, the expansion of the sales organization and in opening up further applications for Cytena's single-cell printers.

Visit our booth at IMAPAC's Biologics World Nordic 2019 in Stockholm, Sweden

cytena is excited to attend the IMAPAC’s “Biologics World Nordic 2019 in Stockholm, Sweden from March 5th-7th.
Visit our booth #6 and get in touch with the most trusted technology for assuring monoclonality by pharma industry!


Our team is looking forward to demonstrate our instruments for Next-Generation Single-Cell Dispensing in Cell Line Development and Single-cell Genomics providing Assurance of Clonality!

 

Our long-time customer Genentech in San Francisco about our single-cell printer: "Leading instrument and great results".

Our long-time customer Genentech in San Francisco has rated our single-cell printer with 4.3 out of 5 points. “Leading instrument and great results”. Especially the value for money and the after sales service were rated as excellent. cytena thanks Genentech for this great review.